303 related articles for article (PubMed ID: 21421700)
21. Sarcolemmal ion channels in dystrophin-deficient skeletal muscle fibres.
Allard B
J Muscle Res Cell Motil; 2006; 27(5-7):367-73. PubMed ID: 16874448
[TBL] [Abstract][Full Text] [Related]
22. Proteome analysis of the dystrophin-deficient MDX diaphragm reveals a drastic increase in the heat shock protein cvHSP.
Doran P; Martin G; Dowling P; Jockusch H; Ohlendieck K
Proteomics; 2006 Aug; 6(16):4610-21. PubMed ID: 16835851
[TBL] [Abstract][Full Text] [Related]
23. Matrix metalloproteinase-2 ablation in dystrophin-deficient mdx muscles reduces angiogenesis resulting in impaired growth of regenerated muscle fibers.
Miyazaki D; Nakamura A; Fukushima K; Yoshida K; Takeda S; Ikeda S
Hum Mol Genet; 2011 May; 20(9):1787-99. PubMed ID: 21320869
[TBL] [Abstract][Full Text] [Related]
24. Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy.
Harper SQ; Hauser MA; DelloRusso C; Duan D; Crawford RW; Phelps SF; Harper HA; Robinson AS; Engelhardt JF; Brooks SV; Chamberlain JS
Nat Med; 2002 Mar; 8(3):253-61. PubMed ID: 11875496
[TBL] [Abstract][Full Text] [Related]
25. From chaos to split-ups--SHG microscopy reveals a specific remodelling mechanism in ageing dystrophic muscle.
Buttgereit A; Weber C; Garbe CS; Friedrich O
J Pathol; 2013 Feb; 229(3):477-85. PubMed ID: 23132094
[TBL] [Abstract][Full Text] [Related]
26. Dissecting the signaling and mechanical functions of the dystrophin-glycoprotein complex.
Judge LM; Haraguchiln M; Chamberlain JS
J Cell Sci; 2006 Apr; 119(Pt 8):1537-46. PubMed ID: 16569668
[TBL] [Abstract][Full Text] [Related]
27. Properties of regenerated mouse extensor digitorum longus muscle following notexin injury.
Head SI; Houweling PJ; Chan S; Chen G; Hardeman EC
Exp Physiol; 2014 Apr; 99(4):664-74. PubMed ID: 24414176
[TBL] [Abstract][Full Text] [Related]
28. Localized expression of specific P2X receptors in dystrophin-deficient DMD and mdx muscle.
Jiang T; Yeung D; Lien CF; Górecki DC
Neuromuscul Disord; 2005 Mar; 15(3):225-36. PubMed ID: 15725584
[TBL] [Abstract][Full Text] [Related]
29. Absence of neuronal nitric oxide synthase (nNOS) as a pathological marker for the diagnosis of Becker muscular dystrophy with rod domain deletions.
Torelli S; Brown SC; Jimenez-Mallebrera C; Feng L; Muntoni F; Sewry CA
Neuropathol Appl Neurobiol; 2004 Oct; 30(5):540-5. PubMed ID: 15488030
[TBL] [Abstract][Full Text] [Related]
30. Pharmacological activation of PPARbeta/delta stimulates utrophin A expression in skeletal muscle fibers and restores sarcolemmal integrity in mature mdx mice.
Miura P; Chakkalakal JV; Boudreault L; Bélanger G; Hébert RL; Renaud JM; Jasmin BJ
Hum Mol Genet; 2009 Dec; 18(23):4640-9. PubMed ID: 19744959
[TBL] [Abstract][Full Text] [Related]
31. Laryngeal muscles are spared in the dystrophin deficient mdx mouse.
Thomas LB; Joseph GL; Adkins TD; Andrade FH; Stemple JC
J Speech Lang Hear Res; 2008 Jun; 51(3):586-95. PubMed ID: 18506037
[TBL] [Abstract][Full Text] [Related]
32. Dystrophin-negative slow-twitch soleus muscles are not susceptible to eccentric contraction induced injury over the lifespan of the
Kiriaev L; Kueh S; Morley JW; Houweling PJ; Chan S; North KN; Head SI
Am J Physiol Cell Physiol; 2021 Oct; 321(4):C704-C720. PubMed ID: 34432537
[TBL] [Abstract][Full Text] [Related]
33. Intestine of dystrophic mice presents enhanced contractile resistance to stretching despite morphological impairment.
Alves GA; Silva LR; Rosa EF; Aboulafia J; Freymüller-Haapalainen E; Souccar C; Nouailhetas VL
Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(3):G191-9. PubMed ID: 24284964
[TBL] [Abstract][Full Text] [Related]
34. Neopterin/7,8-dihydroneopterin is elevated in Duchenne muscular dystrophy patients and protects mdx skeletal muscle function.
Lindsay A; Schmiechen A; Chamberlain CM; Ervasti JM; Lowe DA
Exp Physiol; 2018 Jul; 103(7):995-1009. PubMed ID: 29791760
[TBL] [Abstract][Full Text] [Related]
35. Skeletal muscle-specific expression of a utrophin transgene rescues utrophin-dystrophin deficient mice.
Rafael JA; Tinsley JM; Potter AC; Deconinck AE; Davies KE
Nat Genet; 1998 May; 19(1):79-82. PubMed ID: 9590295
[TBL] [Abstract][Full Text] [Related]
36. The value of mammalian models for duchenne muscular dystrophy in developing therapeutic strategies.
Banks GB; Chamberlain JS
Curr Top Dev Biol; 2008; 84():431-53. PubMed ID: 19186250
[TBL] [Abstract][Full Text] [Related]
37. [Association between dystrophin and neuronal nitric oxide synthase in muscles of progressive muscular dystrophy].
Wang S; Shen D
Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(3):155-7. PubMed ID: 11953148
[TBL] [Abstract][Full Text] [Related]
38. Isometric resistance training increases strength and alters histopathology of dystrophin-deficient mouse skeletal muscle.
Lindsay A; Larson AA; Verma M; Ervasti JM; Lowe DA
J Appl Physiol (1985); 2019 Feb; 126(2):363-375. PubMed ID: 30571283
[TBL] [Abstract][Full Text] [Related]
39. A and B utrophin in human muscle and sarcolemmal A-utrophin associated with tumours.
Sewry CA; Nowak KJ; Ehmsen JT; Davies KE
Neuromuscul Disord; 2005 Nov; 15(11):779-85. PubMed ID: 16198105
[TBL] [Abstract][Full Text] [Related]
40. Increased dysferlin expression in Duchenne muscular dystrophy.
Vontzalidis A; Terzis G; Manta P
Anal Quant Cytopathol Histpathol; 2014 Feb; 36(1):15-22. PubMed ID: 24902367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
